Diabetes increases the risk of disease and death due to Staphylococcus aureus bacteremia. A matched case-control and cohort study

References

• Thomsen RW, Hundborg HH, Lervang HH, et al. Diabetes mellitus as a risk and prognostic factor for community-acquired bacteremia due to enterobacteria: a 10-year, population-based study among adults. Clin Infect Dis. 2005;40:628–631.
   PubMed Web of Science ®Google Scholar
• Thomsen RW, Hundborg HH, Lervang HH, et al. Diabetes and outcome of community-acquired pneumococcal bacteremia: a 10-year population-based cohort study. Diabetes Care. 2004;27:70–77.
   PubMed Web of Science ®Google Scholar
• Benfield T, Espersen F, Frimodt-Moller N, et al. Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000. Clin Microbiol Infect. 2007;13:257–263.
   PubMed Web of Science ®Google Scholar
• Smit J, Sogaard M, Schonheyder HC, et al. Diabetes and risk of community-acquired Staphylococcus aureus bacteremia: a population-based case-control study. Eur J Endocrinol. 2016;174:631–639.
   PubMed Web of Science ®Google Scholar
• Mor A, Berencsi K, Nielsen JS, et al. Rates of community-based antibiotic prescriptions and hospital-treated infections in individuals with and without type 2 diabetes: a Danish Nationwide Cohort Study, 2004-2012. Clin Infect Dis. 2016;63:501–511.
   PubMed Web of Science ®Google Scholar
• Gupta S, Koirala J, Khardori R, et al. Infections in diabetes mellitus and hyperglycemia. Infect Dis Clin North Am 2007;21:617–638.
   PubMed Web of Science ®Google Scholar
• Lipsky BA, Berendt AR, Cornia PB, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012;54:e132–e173.
   PubMed Web of Science ®Google Scholar
• Sogaard M, Norgaard M, Dethlefsen C, et al. Temporal changes in the incidence and 30-day mortality associated with bacteremia in hospitalized patients from 1992 through 2006: a population-based cohort study. Clin Infect Dis. 2011;52:61–69.
   PubMed Web of Science ®Google Scholar
• Laupland KB, Ross T, Gregson DB. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006. J Infect DIS. 2008;198:336–343.
   PubMed Web of Science ®Google Scholar
• Guariguata L, Whiting DR, Hambleton I, et al. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103:137–149.
   PubMed Web of Science ®Google Scholar
• McDonald HI, Nitsch D, Millett ER, et al. New estimates of the burden of acute community-acquired infections among older people with diabetes mellitus: a retrospective cohort study using linked electronic health records. Diabet Med. 2014;31:606–614.
   PubMed Web of Science ®Google Scholar
• Kern WV. Management of Staphylococcus aureus bacteremia and endocarditis: progresses and challenges. Curr Opin Infect Dis. 2010;23:346–358.
   PubMed Web of Science ®Google Scholar
• Leibovici L, Samra Z, Konisberger H, et al. Bacteremia in adult diabetic patients. Diabetes Care. 1991;14:89–94.
   PubMed Web of Science ®Google Scholar
• Bryan CS, Reynolds KL, Metzger WT. Bacteremia in diabetic patients: comparison of incidence and mortality with nondiabetic patients. Diabetes Care. 1985;8:244–249.
   PubMed Web of Science ®Google Scholar
• Cooper G, Platt R. Staphylococcus aureus bacteremia in diabetic patients. Endocarditis and mortality. Am J Med. 1982;73:658–662.
   PubMed Web of Science ®Google Scholar
• Kaasch AJ, Barlow G, Edgeworth JD, et al. Staphylococcus aureus bloodstream infection: a pooled analysis of five prospective, observational studies. J Infect. 2014;68:242–251.
   PubMed Web of Science ®Google Scholar
• Smit J, Thomsen RW, Schonheyder HC, et al. Outcome of community-acquired Staphylococcus aureus bacteraemia in patients with diabetes: a historical population-based Cohort Study. PLoS One. 2016;11:e0153766.
   PubMed Web of Science ®Google Scholar
• Mylotte JM, Tayara A. Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort. Clin Infect Dis. 2000;31:1170–1174.
   PubMed Web of Science ®Google Scholar
• Hill PC, Birch M, Chambers S, et al. Prospective study of 424 cases of Staphylococcus aureus bacteraemia: determination of factors affecting incidence and mortality. Intern Med J. 2001;31:97–103.
   PubMed Web of Science ®Google Scholar
• Kanafani ZA, Kourany WM, Fowler VG, Jr, et al. Clinical characteristics and outcomes of diabetic patients with Staphylococcus aureus bacteremia and endocarditis. Eur J Clin Microbiol Infect Dis. 2009;28:1477–1482.
   PubMed Web of Science ®Google Scholar
• Willcox PA, Rayner BL, Whitelaw DA. Community-acquired Staphylococcus aureus bacteraemia in patients who do not abuse intravenous drugs. QJM. 1998;91:41–47.
   PubMed Web of Science ®Google Scholar
• Pedersen CB, Gotzsche H, Moller JO, et al. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull. 2006;53:441–449.
   PubMed Web of Science ®Google Scholar
• Jessen O, Rosendal K, Bulow P, et al. Changing staphylococci and staphylococcal infections. A ten-year study of bacteria and cases of bacteremia. N Engl J Med. 1969;281:627–635.
   PubMed Web of Science ®Google Scholar
• Mejer N, Westh H, Schonheyder HC, et al. Stable incidence and continued improvement in short term mortality of Staphylococcus aureus bacteraemia between 1995 and 2008. BMC Infect Dis. 2012;12:1471–2334.
   Web of Science ®Google Scholar
• Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health. 2011;39:30–33.
   PubMed Web of Science ®Google Scholar
• Green A, Sortsø C, Jensen PB, et al. Validation of the Danisah National Diabetes Register. Clin Epidemiol. 2015;7:5–15.
   PubMed Web of Science ®Google Scholar
• Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130–1139.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383.
   PubMedGoogle Scholar
• Gotland N, Uhre ML, Mejer N, et al. Long-term mortality and causes of death associated with Staphylococcus aureus bacteremia. A matched cohort study. J Infect. 2016;73:346–357.
   PubMed Web of Science ®Google Scholar
• Bassetti M, Trecarichi EM, Mesini A, et al. Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia. Clin Microbiol Infect. 2012;18:862–869.
   PubMed Web of Science ®Google Scholar
• Jacobsson G, Dashti S, Wahlberg T, et al. The epidemiology of and risk factors for invasive Staphylococcus aureus infections in Western Sweden. Scand J Infect Dis. 2007;39:6–13.
   PubMed Web of Science ®Google Scholar
• Laupland KB, Church DL, Mucenski M, et al. Population-based study of the epidemiology of and the risk factors for invasive Staphylococcus aureus infections. J Infect Dis. 2003;187:1452–1459.
   PubMed Web of Science ®Google Scholar
• Benfield T, Jensen JS, Nordestgaard BG. Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome. Diabetologia 2007;50:549–554.
   PubMed Web of Science ®Google Scholar
• Umpierrez G, Korytkowski M. Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia. Nat Rev Endocrinol. 2016;12:222–232.
   PubMed Web of Science ®Google Scholar
• Rangel-Frausto MS, Pittet D, Costigan M, et al. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995;273:117–123.
   PubMed Web of Science ®Google Scholar
• Medeiros P, Nga HS, Menezes P, et al. Acute kidney injury in septic patients admitted to emergency clinical room: risk factors and outcome. Clin Exp Nephrol. 2015;19:859–866.
   PubMed Web of Science ®Google Scholar